Audeotherapy.com
Audeotherapy.com

Terms and Conditions

Terms and Conditions
Last Updated: 12/25/2024

Welcome to AudeoTherapy! By accessing or using our website and services, you agree to comply with and be bound by these Terms and Conditions (“Terms”). Please review them carefully before using our services.

1. Introduction

AudeoTherapy is committed to delivering high-quality information and products to its users. These Terms outline the rules and guidelines for utilizing our website and services. By accessing our platform, you agree to these Terms. If you disagree with any portion, please discontinue using our website immediately.

2. Eligibility

By using AudeoTherapy’s services, you confirm that you are at least 18 years old and legally authorized to enter agreements. Additionally, you agree to provide accurate and up-to-date information during your use of our services.

3. Disclaimer

All content on this website is for informational purposes only and does not replace professional advice, evaluation, or treatment. Products and services offered by AudeoTherapy are designed to assist professionals in making informed decisions but should not be used as a substitute for professional guidance. We encourage consulting qualified professionals before initiating or discontinuing any action based on the information provided.

AudeoTherapy assumes no responsibility for injuries, damages, or other outcomes resulting from the misuse of our products or services.

4. Product Use and Compliance

Products provided by AudeoTherapy are prepared in accordance with relevant regulations. Unless explicitly stated, they are not FDA-approved and require valid authorization or prescriptions, where applicable. While we strive for excellence, AudeoTherapy does not guarantee the safety or effectiveness of any product for specific applications.

5. Intellectual Property

The content on this website, including text, images, logos, and related materials, is the exclusive intellectual property of AudeoTherapy. Unauthorized use, reproduction, or distribution of this content is strictly prohibited and may result in legal action.

6. Limitation of Liability

To the fullest extent allowed by law, AudeoTherapy is not liable for any direct, indirect, incidental, or consequential damages that may arise from the use or inability to use our services or products. This includes, but is not limited to, financial losses, data breaches, or operational downtime.

7. Privacy Policy

Your privacy matters to us. By using AudeoTherapy’s services, you agree to our collection and use of your data per the guidelines outlined in our Privacy Policy.

8. Prohibited Activities

You are prohibited from using AudeoTherapy’s website or services for:

  • Unlawful activities.
  • Actions infringing the rights of others.
  • Introducing malware, viruses, or malicious code.

Any violation may result in immediate termination of your access to our services.

9. Changes to These Terms

AudeoTherapy reserves the right to revise these Terms without prior notice. By continuing to use our services after changes are made, you indicate your acceptance of the updated Terms.

10. Intended Use

All products offered by AudeoTherapy are intended solely for research purposes unless otherwise specified. They are not manufactured for diagnostic, therapeutic, or clinical applications unless explicitly approved by licensed professionals. By purchasing, you agree to use these products strictly for lawful research activities and comply with all applicable laws and regulations.

11. Contact Information

If you have questions or concerns regarding these Terms, please reach out to us:
AudeoTherapy
[Brandname]
[Phone]
[Email]
[Address]

Acknowledgment
By using AudeoTherapy’s website and services, you acknowledge that you have read, understood, and agreed to these Terms and Conditions.

Scroll to Top

Safety Information

Critical Details About Compounded Semaglutide

Compounded medications are legally allowed to be prescribed under federal law; however, they are not FDA-approved and do not undergo FDA evaluation for safety, efficacy, or production standards. At AudeoTherapy, compounded semaglutide is prescribed based on an individualized medical assessment.

WARNING: Potential Risk of Thyroid C-Cell Tumors
Research in animals has linked semaglutide, the active ingredient in some GLP-1 receptor agonists, to thyroid tumors, including medullary thyroid carcinoma (MTC). It is unclear if semaglutide causes similar tumors in humans. Notify your healthcare provider immediately if you notice symptoms of thyroid cancer, such as neck lumps or swelling, hoarseness, swallowing difficulties, or shortness of breath. Compounded semaglutide is not suitable for individuals with personal or family histories of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Uses of Compounded Semaglutide
Compounded semaglutide is intended for use alongside a reduced-calorie diet and increased physical activity to manage chronic weight in adults who meet the following criteria:

  • A body mass index (BMI) of 30 kg/m² or higher (classified as obesity), or
  • A BMI of 27 kg/m² or higher (overweight) with at least one weight-related condition, such as type 2 diabetes, hypertension, or abnormal cholesterol levels.

Usage Restrictions

  • Do not use compounded semaglutide in combination with other GLP-1 receptor agonists or semaglutide-containing products.
  • Its safety and effectiveness when combined with other weight management medications have not been established.
  • Patients with a history of pancreatitis or gastroparesis have not been studied for this treatment.

Avoid Use If You:

  • Have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2.
  • Are diagnosed with type 1 diabetes, pancreatitis, or gastroparesis.
  • Are allergic to semaglutide or any inactive ingredients.
  • Have a history of suicidal thoughts or behavior.

Precautions and Warnings:

  • Acute Pancreatitis: Stop using the medication if pancreatitis is suspected.
  • Gallbladder Issues: Monitor for symptoms of gallbladder disease, including gallstones, and seek medical advice as needed.
  • Low Blood Sugar: When combined with insulin or similar medications, there is an increased risk of hypoglycemia. Regularly monitor blood sugar and adjust doses as recommended by your provider.
  • Kidney Health: Monitor kidney function, particularly in patients with renal impairment or those experiencing severe gastrointestinal effects.
  • Mental Health Concerns: Watch for mood changes, depression, or suicidal thoughts, and discontinue use if these symptoms occur.

Pregnancy and Fertility Considerations
Semaglutide may harm an unborn child. Avoid use during pregnancy or if planning to become pregnant. Stop treatment at least two months before attempting to conceive.

Common Side Effects:
Frequently reported side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, headaches, and low blood sugar in patients with type 2 diabetes.

Potential Drug Interactions:
Compounded semaglutide slows gastric emptying, which could impact the absorption of oral medications. Consult your healthcare provider to manage potential interactions effectively.

Medication Disclaimer

Essential Information on Medications: Saxenda®, Victoza®, Wegovy®, and Ozempic® are patented products of Novo Nordisk™, while Eli Lilly and Company™ produce Mounjaro™ and Zepbound. This website is not affiliated with, endorsed by, or connected to these companies or their products in any capacity. While these FDA-approved medications may be available through other sources, we do not provide them, and they are currently experiencing supply shortages. During such shortages, pharmacies might prepare compounded versions of these drugs, provided they comply with the Federal Food, Drug, and Cosmetic Act’s requirements. Compounded medications are valuable for patients with unique medical needs that FDA-approved drugs cannot address. However, it is important to note that compounded drugs are not FDA-approved, nor do they undergo premarketing evaluations for safety, effectiveness, or quality. The FDA has not assessed these medications for their intended uses, nor has the manufacturing process for compounded drugs been reviewed by the FDA.